To build a more beautiful future we have to recode innovation. By intersecting the needs of people, planet, and business, we will create more positive emotions with less consumption, build more robust systems, and deliver the biggest possible and viable advancement towards a better future for all life on earth.
Humane Innovations are characterized by three qualities:
- Keeping products and materials in use and minimizing their negative impact through circular business models and production
- Supporting a shift from self-interest and instant gratification to collective care and social impact
- Bringing the best oft humanity to the task of improving all life on planet
The contest
Making hardware circular usually means adding services. That said you need a team of designers, engineers, business and communication strategist as well as money to make that happen.
With all that we can help!
Enter our „humane innovation“-contest and experience what’s possible if you really want to improve all life on the planet and succeed. Just answer our questionnaire until August 31st as detailed as possible. We will pick one entry qhich is most promising to deliver the biggest possible and viable advancement towards a better future for all life on earth in the given span of 3-4 months (within a budget of our site of € 25k.)
More News
Pacira BioSciences Acquires GQ Bio
HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...
Read more …
CrystalsFirst Scales Operations...
CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...
Read more …
Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT
medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
Read more …